Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine plus ketorolac versus ketorolac plus placebo for renal colic in the emergency department
IRCT20190217042738N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Renal colic comparing Papaverine + Ketorolac with Ketorolac + Placebo (2 arms). Primary endpoint: Pain reduction at 60 minutes. Started Apr 2018; status: completed.
02
Drugs
papaverineketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on IRCT20190217042738N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190217042738N1.